Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

Clinical trial NCT00503412 · COMPLETED

Trial details

NCT number: NCT00503412
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Metastatic Tumor

Start date: 2005-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.